EUVIMEDEUVIMED entdecken
Open Access

Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants

William J Jeang iD, Bryan M Wong, Yichao Zhao, Rajith S Manan, Alexis L Jiang, Suman Bose, Evan Collins, Patrick McMullen, Jan-Georg Rosenboom, Sushil Lathwal, Robert Langer iD, Daniel G Anderson iD

Advanced Materials · 2025-02 · 37 (7)

DOI: 10.1002/adma.202414743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 25.12.2024. Verfasst von William J Jeang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Hauptthemen laut MEDLINE: Polymers, Prostheses and Implants, Biofouling, Immunologic Factors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Foundation Graduate Research Fellowship Program, NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune reactions to medical implants often lead to encapsulation by fibrotic tissue and impaired device function. This process is thought to initiate by protein adsorption, which enables immune cells to attach and mount an inflammatory response. Previously, several antifibrotic materials have been either designed to reduce protein adsorption or discovered via high‐throughput screens (HTS) to favorably regulate inflammation. The present work introduces antifouling immunomodulatory (AIM) copolymer coatings, which combine both strategies to effectively enhance implant protection. AIM copolymers synergistically integrate zwitterionic moieties to resist protein fouling, HTS‐derived antifibrotics for immunomodulation, and silane monomers for grafting to diverse substrates including elastomers, ceramics, and metals. Interestingly, simply combining these monomers into conventional random or block copolymer architectures yielded no significant advantage over homopolymers. By contrast, an unusual polymer chain architecture — a zwitterionic block flanked by a mixed zwitterionic immunomodulatory segment — showed superior fibrosis resistance in both peritoneal and subcutaneous sites over one month in immunocompetent mice. This architecture also improved the performance of two different HTS‐derived antifibrotic monomers, suggesting that tailoring AIM architectures may broadly complement immunomodulatory chemistries and provide a versatile approach to improving implant longevity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolymersProstheses and ImplantsBiofoulingImmunologic FactorsCoated Materials, BiocompatibleAnimalsMiceFibrosis

Stichwörter der Autor:innen

antifoulingbiomaterialscoatingsfibrosisimmune responseimplantspolymers

Substanzen

PolymersImmunologic FactorsCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Department of Anesthesiology, Critical Care Pain Medicine, Boston Children Hospital, Boston, MA, 02115, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Department of Computer Science, Wellesley College, Wellesley, MA, 02481, USA.

ORCID-Profile: William J Jeang, Robert Langer, Daniel G Anderson

Förderung

  • National Science Foundation Graduate Research Fellowship Program
  • NCI NIH HHS
  • NIBIB NIH HHS
  • NIH HHS
  • Juvenile Diabetes Research Foundation International
  • National Institutes of Health
  • National Cancer Institute
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Jeang, W. J., Wong, B. M., Zhao, Y., Manan, R. S., Jiang, A. L., Bose, S., Collins, E., McMullen, P., Rosenboom, J. G., Lathwal, S., Langer, R., & Anderson, D. G. (2025). Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants. Advanced Materials, 37(7). https://doi.org/10.1002/adma.202414743

Vancouver

Jeang WJ, Wong BM, Zhao Y, Manan RS, Jiang AL, Bose S, et al. Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants. Advanced Materials. 2025;37(7). doi:10.1002/adma.202414743

BibTeX
@article{Jeang2025,
  author = {Jeang, William J and Wong, Bryan M and Zhao, Yichao and Manan, Rajith S and Jiang, Alexis L and Bose, Suman and Collins, Evan and McMullen, Patrick and Rosenboom, Jan-Georg and Lathwal, Sushil and Langer, Robert and Anderson, Daniel G},
  title = {Antifouling Immunomodulatory Copolymer Architectures That Inhibit the Fibrosis of Implants},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {7},
  doi = {10.1002/adma.202414743}
}
Kostenlos starten →